Table 7.

Mortality rate in the ceftaroline and control groups

Study	Mortality rate, n (%)
	Ceftaroline group	Control group
Jandourek et al, 2014	–	–
File et al, 2011	6/298 (2.0)	6/308 (1.9)
Low et al, 2011	9/315 (2.9)	6/307 (2.0)
Shorr et al, 2013	–	1/70 (1.4)
File et al, 2010	15/613 (2.4)	12/615 (2.0)
Zhong et al, 2015	3/381 (0.8)	4/383 (1.0)
Arshad et al, 2016 28-day mortality	4/40 (10.0)a	16/109 (14.7)a
Eckburg et al, 2012	–	–
Ramani et al, 2014	8/398 (2.0)b	–
Casapao et al, 2014	13/92 (14.1)b	–
Vasquez et al, 2015	1/21 (4.8)	–
Guervil et al, 2015	8/396 (2.0)b	–
Kaye et al, 2015	5/40 (12.5)	–
Udeani et al, 2014	15/528 (2.8)	–

^a28-day mortality

^b Hospital mortality